|
⚲
|
| Keyboard |
| Millennium Management LLC
✚
|
|
|---|---|
| CRD # | 158117 |
| SEC # | 801-73884 |
| CIK # | 0001426821, 0001605917, 0001273087, 0001446830 |
| AUM | 720.85 B (2026-03-31) |
| Employees | 6,670 (46% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-841-4100 |
| Address | 399 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] [Instagram] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Fri, 24 Jul 2026 | Millennium Management LLC Reduces Stake in Tenax Therapeutics Inc — GuruFocus |
| Fri, 24 Jul 2026 | Millennium Management LLC Reduces Stake in Contineum Therapeutics Inc — GuruFocus |
| Wed, 22 Jul 2026 | Millennium Management LLC Reduces Stake in Bleichroeder Acquisition Corp II — GuruFocus |
| Fri, 17 Jul 2026 | Millennium Management LLC Reduces Stake in Elme Communities — GuruFocus |
| Fri, 17 Jul 2026 | Millennium Management LLC Reduces Stake in Byrna Technologies Inc — GuruFocus |
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5 Fees and Compensation
Funds
The fees, expenses and/or allocations associated with an investment in a Fund vary, depending on the specific Fund,
and are detailed in the Fund’s offering document. Any applicable fees, expenses and/or allocations are deducted from
a Fund investor’s assets as described in such Fund’s offering document.
Performance-based allocations or fees are generally allocated or paid, respectively, annually and upon an investor’s
withdrawal or redemption from the applicable Fund. In the case of one Millennium Partners Fund, asset-based fees
are paid quarterly in advance and are generally subject to proration for (i) a subscription that does not fall on the first
day of a quarter or (ii) a withdrawal or redemption that does not fall on the last day of a quarter.
Millennium Partners, L.P. (“Millennium Partners”) and its Feeder Funds (together with Millennium Partners as the
context may require, the “Millennium Partners Funds”)
The Millennium Partners Funds generally bear, directly or indirectly, all expenses incurred in connection with the
operation of the Millennium Partners Funds, without limitation (which are therefore borne by the investors in the
Millennium Partners Funds), other than as described in Item 11 under “Portfolio Manager Investment in Own
Strategies.” We generally refer to this as an “expense pass-through.” Each Millennium Partners Fund also pays us a
performance-based allocation and/or an asset-based fee, and is generally responsible for:
a generally pro rata portion of all of the fees and expenses that such Millennium Partners Fund and
its affiliates incur (which include, among other things, the salaries, fringe benefits, bonuses, fees and
performance-based compensation (collectively, “compensation”) and expenses paid or reimbursed
to Portfolio Managers (as defined in Item 8 of this Brochure), other employees, consultants,
subcontractors and agents, fees paid to persons or entities who assist in identifying and recruiting
Portfolio Managers, expenses related to computers and other equipment and expenses related to
maintaining offices, including leases and fixtures); and
all fees and expenses incurred in connection with any transactions, engagements, and other
agreements that such Millennium Partners Fund enters into on its own behalf, including, among
other things, costs and expenses of its administrator, expenses incurred in connection with the private
placement of interests (other than placement fees), and, with respect to non-U.S. Millennium
Partners Funds, directors’ fees and expenses.
Millennium Partners Funds in the aggregate bear all of the compensation paid to the Portfolio Managers
(including Portfolio Managers that are Relying Advisers) and other employees of, and consultants to, the
Firm and its affiliates. The compensation expenses also include management or “base” fees that are charged
by certain Portfolio Managers or third-party funds. In addition, certain personnel who assist in overseeing
groups of Portfolio Managers (e.g., the head of a particular strategy) receive compensation based on the
overall performance of such Portfolio Managers. This compensation of Portfolio Managers and such
personnel responsible for overseeing Portfolio Managers (as well as other Millennium employees) is separate
from and in addition to the performance- and/or asset-based compensation we receive from the Millennium
Partners Funds, which compensates us for services provided by our principal. Such expense is deducted prior
to calculation of the performance- and/or asset-based compensation we receive from the Millennium Partners
Funds. Compensation of a Portfolio Manager is generally determined as a percentage of profits earned by
such Portfolio Manager during the preceding calendar year, with profits measured on an accrual (i.e., mark-
to-market) basis and without taking into account the performance of other Portfolio Managers or of the
Millennium Partners Funds generally. If a Portfolio Manager suffers net losses during the year, generally the
losses are carried forward and past losses must be made up before performance-based compensation becomes
payable in subsequent years. Portfolio Managers also receive a salary, which is generally treated as an
advance against their performance-based compensation if there are profits (although, for certain Portfolio
Managers, salary is instead treated as an expense of their respective accounts). There is generally no
“carryback” or “clawback” of losses to permit recouping of performance-based compensation from prior
years. Portfolio Managers with positive performance will receive performance-based compensation even if
the Millennium Partners Funds’ overall returns are negative. We have agreed, and may in the future agree,
to “guarantee” a level of compensation for a Portfolio Manager or other personnel for a particular year (or
years) or to replace compensation that a Portfolio Manager or other personnel has forfeited in connection with
the termination of prior employment. We have from time to time in the past negotiated, and may in the future
negotiate, different compensation arrangements with Portfolio Managers and other personnel than those
described above.
In addition to the expenses listed above, the expenses of the Millennium Partners Funds, which are paid
directly or indirectly by such Millennium Partners Funds, include all expenses directly or indirectly related
... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7 Types of Clients We manage private funds, and certain Relying Advisors have entered into separately managed account agreements to provide discretionary investment advisory services to certain institutional investors. In the future, we may provide investment advice to other clients, including other funds and separately managed accounts. We require Separate Account Clients to enter into a written investment management agreement. Minimum account sizes will vary and we may waive any account minimum. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Nvidia Corp | 7.3 | ||
| Apple Inc | 4.7 | ||
| Microsoft Corp | 4.6 | ||
| Facebook Inc | 4.1 | ||
| Amazon Com Inc | 3.8 | ||
| Tesla Motors Inc | 3.1 | ||
| Alphabet Inc | 3.0 | ||
| Broadcom Inc | 2.1 | ||
| Alphabet Inc | 1.8 | ||
| Advanced Micro Devices Inc | 1.7 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | WMA Systematic Alpha Broad US Equity Return Master Fund LP | [2026-02-03] | 43.4 M | |
| Filed 2026-01-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA US Large Cap Enhanced Equity Master Fund LP | [2026-02-03] | 299.1 M | |
| Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA International Ex-US Ex-HK Active Extension Master Fund LP | [2025-09-30] | 1,286.9 M | |
| Filed 2025-08-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA US Active Extension Master Fund LP | [2025-08-14] | 2,752.4 M | |
| Filed 2025-05-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA Global Large Cap Enhanced Equity Master Fund LP | [2025-02-05] | 378.3 M | |
| Filed 2024-10-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA AE Institutional Fund I LP | [2023-11-27] | 400.5 M | 917.6 M |
| Filed 2025-07-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA Systematic Equity Alpha Long/Short Master Fund LP | [2023-02-27] | 528.7 M | 3,218.5 M |
| Filed 2025-05-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA International Equity 130/30 Master Fund LP | [2019-02-20] | 454.4 M | 0.1 M |
| Filed 2020-12-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMA US Equity 130/30 Master Fund LP | [2019-02-20] | 636.0 M | 546.9 M |
| Filed 2021-12-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | WMQS Global Equity Active Extension Master Fund LP | [2018-08-24] | 1,277.9 M | 12.76 B |
| Filed 2025-04-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 27 | 709.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 1.3 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 10.3 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 35 | 720.8 |
| By Discretionary | ||
| Discretionary | 35 | 720.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 35 | 720.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 661.3 | |
| United States Persons | 59.5 | |
| Total | 35 | 720.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ebony Myles-Berry | Director | 93 | 36 | |
| Ian Goodall | Director | 141 | 33 | |
| Michael McDonald | Director | 123 | 30 | |
| Robert Williams | Executive Officer | 30 | 3 | |
| Michael Gelband | Executive Officer | 9 | 3 | |
| Kevin Byrne | Executive Officer | 6 | 3 | |
| David Nolan | Executive Officer | 19 | 2 | |
| Israel Englander | Executive Officer, Promoter | 13 | 2 | |
| Simon Lorne | Executive Officer | 8 | 2 | |
| Igor Tulchinsky | Promoter | 8 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001273087] | |
| 3 | [0001273087] | |
| 4 | [0001273087] | |
| SC 13G | [0001273087] | |
| 13F-NT | [0001426821] | |
| 3 | [0001426821] | |
| 4 | [0001426821] | |
| 3 | [0001446830] | |
| 4 | [0001446830] | |
| D | [0001605917] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $156.7B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300D0DN3CHSCJ0I36 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CXApp Inc CXAI
Class A Common Stock
|
2022-12-28 | Other | 175,000 | $10.12 | 1,771,000 |
|
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
|
2021-12-17 | Sell | 300,000 | $9.87 | 2,961,000 |
|
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
|
2021-11-12 | Buy | 30,681 | $9.92 | 304,356 |
|
FiscalNote Holdings Inc DSAC
Class A Ordinary Shares, par value $0.0001 per share
|
2021-11-08 | Buy | 54,773 | $9.92 | 543,348 |
|
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
|
2020-06-03 | Sell | 209,699 | $10.45 | 2,191,355 |
|
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
|
2020-06-03 | Sell | 91 | $10.50 | 956 |
|
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
|
2020-06-03 | Sell | 189 | $10.52 | 1,988 |
|
Megalith Financial Acquisition Corp MFAC
Class A Common Stock, par value $0.0001 per share
|
2020-06-03 | Sell | 21 | $10.55 | 222 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-17 | Sell | 216,200 | $3.65 | 789,130 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-13 | Sell | 100,000 | $3.71 | 371,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-13 | Sell | 100,000 | $3.65 | 365,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-12 | Sell | 100,000 | $3.58 | 358,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-11 | Sell | 100,000 | $3.50 | 350,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-06 | Sell | 75,000 | $3.53 | 264,750 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-02-05 | Sell | 100,000 | $3.35 | 335,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-01-30 | Sell | 75,000 | $3.27 | 245,250 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-01-28 | Sell | 100,000 | $3.17 | 317,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2015-01-15 | Sell | 50,000 | $3.15 | 157,500 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2014-06-27 | Sell | 100,000 | $4.00 | 400,000 |
|
Liberator Medical Holdings Inc LBMH
Common Stock
|
2014-06-24 | Sell | 175,000 | $4.05 | 708,750 |
| showing 20 of 38 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
BlackRock Advisors LLC
✚
|
NY | 1,096.12 B |
|
Nomura Asset Management Co Ltd
✚
|
601.79 B | |
|
Massachusetts Financial Services Company
✚
|
MA | 514.05 B |
|
Arrowstreet Capital Limited Partnership
✚
|
MA | 351.32 B |
|
Legal & General Investment Management America Inc
✚
|
IL | 267.16 B |
|
Amova Asset Management Co Ltd
✚
|
247.43 B | |
|
Two Sigma Investments LP
✚
|
NY | 232.82 B |
|
Squarepoint Ops LLC
✚
|
NY | 226.98 B |
|
Schonfeld Strategic Advisors LLC
✚
|
NY | 225.25 B |
|
Rokos Capital Management LLP
✚
|
219.44 B |